News
WHO warns of 10,000 new weekly Ebola cases
The World Health Organisation (WHO) has warned West Africa may face up to 10,000 new Ebola cases per week within two months, due...
Research Insight
Hikma to market Eisai’s epilepsy treatment Fycompa in Middle East
UK-based Hikma Pharmaceuticals has partnered with Eisai to distribute first-class epilepsy treatment Fycompa (perampanel) in the Middle East. Eisai ...
Research Insight
Gilead’s Harvoni receives FDA approval for hepatitis C genotype 1 infection
Gilead Sciences has received approval from US Food and Drug Administration for Harvoni (ledipasvir 90mg/sofosbuvir 400mg), a once-daily single tablet regimen to...
Clinical Trials
The Netherlands-based company Prosena has begun the submission process for drisapersen, its treatment for Duchenne muscular dystrophy (DMD).
The news is a remarkable turnaround for the drug, which had looked doomed to failure just a few months ago. In January this year,...
News
Five women who claim they suffered sex discrimination while working as sales reps for Merck have been told that the company’s motion to dismiss...
The women – all current or former employees – are seeking $250 million in damages for claims that the drug maker allowed discriminatory and...
Press Releases
Endo International has persuaded Auxilium Pharma into a takeover that leaves an earlier plan to merge Auxilium with QLT in tatters.
Ireland-based Endo has made a $2.6bn cash-and-stock offer for Auxilium - which has been approved by the boards of both companies - that will...
Press Releases
Pharming and Swedish Orphan Biovitrum Amend and Extend Ruconest Distribution Agreement
Pharming to Directly Commercialise Ruconest in Austria Germany and NetherlandsBiotech company Pharming Group NV ("Pharming" or "the Company") (EURONEXT: PHARM) and Swedish Orphan Biovitrum...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read